PHYTOSOMES: A DYNAMIC INNOVATION IN CANCER TREATMENT

Year 2024, Volume: 27 Issue: Current Research Topıcs In Pharmacy: An Overview of Novelties in Cancer Treatment, 2 - 3, 28.06.2025

Dhanashree P. Sanap

Abstract

Phytosomes present a promising avenue for revolutionizing the administration of herbal medications, particularly in the context of cancer treatment. This innovative approach involves enhancing the absorption and creating a unique dosage form for plant extracts through the incorporation of phosphatidylcholine. In contrast to pharmaceuticals derived from synthetic compounds, phytosomal systems hold significant potential for elevating therapeutic efficacy while concurrently mitigating adverse effects, making them particularly relevant in cancer therapy. Within the realm of phytotherapy, the focal points lie in the production and utilization of phytosomes as advanced delivery systems for cancer treatment. Critical evaluation factors such as particle size, zeta potential, and entrapment efficiency play a pivotal role in determining the effectiveness of phytosomal formulations. Thorough assessments of these parameters are essential to ensure the optimal quality and efficacy of phytosomal formulations specifically tailored for cancer treatment. Future applications of phytosomal delivery techniques in cancer treatment exhibit substantial market potential. This is particularly noteworthy given the growing preference for natural remedies over conventional options in the realm of oncology. Phytosomes have the potential to emerge as a groundbreaking approach in cancer therapy, offering enhanced therapeutic outcomes with minimized side effects, aligning with the evolving landscape of holistic and natural treatment preferences in the medical community.

Keywords

phytosomes , herbal medicines , cancer treatment

References

• [1] Gaikwad SS, Morade YY, Kothule AM, Kshirsagar SJ, Laddha UD, Salunkhe KS. Overview of phytosomes in treating cancer: advancement, challenges, and future outlook. Heliyon. 2023; 9(6):e16561. https://doi.org/10.1016/j.heliyon.2023.e16561.
• [2] Komeil IA, Abdallah OY, El-Refaie WM. Surface modified genistein phytosome for breast cancer treatment: In-vitro appraisal, pharmacokinetics, and in-vivo antitumor efficacy. Eur J Pharm Sci. 2022; 179:106297. https://doi.org/10.1016/j.ejps.2022.106297.
• [3] Komeil IA, Gowayed MA, El-Ganainy SO, El Achy SN, Huttunen KM, Abdallah OY. Oral genistein-loaded phytosomes with enhanced hepatic uptake, residence and improved therapeutic efficacy against hepatocellular carcinoma. Int J Pharm. 2021; 601: 120564. https://doi.org/10.1016/j.ijpharm.2021.120564.
• [4] Padmakumari P, Manda RM. Design, formulation, biopharmaceutical evaluation and in-vitro screening of boldine phytosomes for breast cancer therapy. Materials Today: Proceedings. 2023. https://doi.org/10.1016/j.matpr.2023.08.123.
• [5] Komeil I, El Refaie W, Abdallah O. Genistein-loaded phytosomes for treatment of liver cancer via oral administration. World Patent WO 135652. 2022; 1-54. French.
• [6] Murugesan MP, Ratnam MV, Mengitsu Y, Kandasamy K. Evaluation of anti-cancer activity of phytosomes formulated from Aloe vera extract. Materials Today: Proceedings. 2021; 42(2): 631-636. https://doi.org/10.1016/j.matpr.2020.11.047.